CHNA Holdings

CNCR

The China BioPharma ETF

ETF Information as of 11/15/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
SINOPHARM GROUP CO 1099 HK B3ZVDV0 28,000 $140,691.84 6.44%
WUXI BIOLOGICS (CA 2269 HK BZ3C3R5 13,000 $108,564.35 4.97%
SSY GROUP LIMITED 2005 HK BYP9J68 104,000 $107,037.15 4.90%
CSPC PHARMACEUTICA 1093 HK 6191997 48,000 $106,894.13 4.89%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR HCM 44842L103 2,757 $100,906.20 4.62%
SHANGHAI FOSUN PHA 2196 HK B8XBQ96 27,000 $94,122.30 4.31%
CHINA RES PHARM GR 3320 HK BYNGG26 60,000 $93,471.07 4.28%
SIHUAN PHARM HLDG 460 HK B4X3RF7 426,000 $93,019.04 4.26%
BEIGENE LTD BGNE 07725L102 708 $89,916.00 4.12%
GUANGZHOU BAIYUNSH 874 HK 6084387 22,000 $88,912.44 4.07%
SINO BIOPHARMACEUT 1177 HK B00XSF9 92,000 $87,285.64 4.00%
SHANGHAI PHARMACEU 2607 HK B4Q4CJ6 33,600 $83,406.84 3.82%
LUYE PHARMA GP LTD 2186 HK BNQ4GF3 93,000 $75,646.44 3.46%
GENSCRIPT BIOTECH 1548 HK BD9Q2J2 40,000 $75,083.32 3.44%
CHINA GRAND PHARMA 512 HK B00W4D6 140,000 $71,686.69 3.28%
SHANGHAI HAOHAI BI 6826 HK BWZN1R1 12,200 $68,467.56 3.13%
LIVZON PHARMACEUTI 1513 HK BJ34614 19,400 $67,628.62 3.10%
ZAI LAB LTD ZLAB 98887Q104 3,856 $67,480.00 3.09%
CHINA BIOLOGIC PRODS HLDGS INC COM CBPO G21515104 916 $66,712.28 3.05%
AUSTAR LIFESCIENCE 6118 HK BSHYHZ4 136,000 $65,470.61 3.00%
ASCLETIS PHARMA IN 1672 HK BFLTDL2 62,000 $64,285.62 2.94%
3SBIO INC 1530 HK BY9D3L9 41,000 $62,824.82 2.88%
YICHANG HEC CHANGJ 1558 HK BYPHSW1 17,600 $61,578.54 2.82%
CHINA MEDICAL SYS 867 HK B6WY993 49,000 $57,313.60 2.62%
LEES PHARMACEUTICA 950 HK BQZF1T7 66,000 $52,336.14 2.40%
ESSEX BIO-TECHNOLO 1061 HK 6370291 74,000 $52,159.92 2.39%
CELLULAR BIOMEDICINE GROUP INC COM NEW CBMG 15117P102 2,904 $50,326.32 2.30%
CASI PHARMACEUTICALS INC CASI 14757U109 8,508 $29,948.16 1.37%
Cash & Other Cash&Other Cash&Other 1,134.35 $1,134.35 0.05%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities